These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22197139)

  • 1. Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications.
    McCauley JP; Dantzman CL; King MM; Ernst GE; Wang X; Brush K; Palmer WE; Frietze W; Andisik DW; Hoesch V; Doring K; Hulsizer J; Bui KH; Liu J; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1169-73. PubMed ID: 22197139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Piperidin-4-ylidenemethyl-benzamides as δ-opioid receptor agonists for CNS indications: identifying clinical candidates.
    Dantzman CL; King MM; Ernst GE; Wang X; McCauley JP; Andisik DW; Brush K; Bui KH; Frietze W; Hoesch V; Liu J; Palmer WE; Spear N; Hudzik TJ; Wesolowski SS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1174-8. PubMed ID: 22197137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
    Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
    J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
    Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
    Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
    J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioconvergent synthesis of (-)-(2R,5S)-1-allyl-2,5-dimethylpiperazine, an intermediate to delta-opioid receptor ligands.
    Janetka JW; Furness MS; Zhang X; Coop A; Folk JE; Mattson MV; Jacobson AE; Rice KC
    J Org Chem; 2003 May; 68(10):3976-80. PubMed ID: 12737580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).
    Le Bourdonnec B; Windh RT; Leister LK; Zhou QJ; Ajello CW; Gu M; Chu GH; Tuthill PA; Barker WM; Koblish M; Wiant DD; Graczyk TM; Belanger S; Cassel JA; Feschenko MS; Brogdon BL; Smith SA; Derelanko MJ; Kutz S; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
    J Med Chem; 2009 Sep; 52(18):5685-702. PubMed ID: 19694468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of SNC80 analogues with a bridged piperazine ring.
    Holl R; Jung B; Schepmann D; Humpf HU; Grünert R; Bednarski PJ; Englberger W; Wünsch B
    ChemMedChem; 2009 Dec; 4(12):2111-22. PubMed ID: 19827086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel N-aryl piperazine CXCR4 antagonists.
    Zhao H; Prosser AR; Liotta DC; Wilson LJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4950-4955. PubMed ID: 25935642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
    Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
    Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacology of AZD2327: a highly selective agonist of the δ-opioid receptor.
    Hudzik TJ; Maciag C; Smith MA; Caccese R; Pietras MR; Bui KH; Coupal M; Adam L; Payza K; Griffin A; Smagin G; Song D; Swedberg MD; Brown W
    J Pharmacol Exp Ther; 2011 Jul; 338(1):195-204. PubMed ID: 21444630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
    Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology.
    Owen DR; Rodriguez-Lens M; Corless MD; Gaulier SM; Horne VA; Kinloch RA; Maw GN; Pearce DW; Rees H; Ringer TJ; Ryckmans T; Stammen BL
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1702-6. PubMed ID: 19231185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859).
    Le Bourdonnec B; Windh RT; Ajello CW; Leister LK; Gu M; Chu GH; Tuthill PA; Barker WM; Koblish M; Wiant DD; Graczyk TM; Belanger S; Cassel JA; Feschenko MS; Brogdon BL; Smith SA; Christ DD; Derelanko MJ; Kutz S; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
    J Med Chem; 2008 Oct; 51(19):5893-6. PubMed ID: 18788723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.
    Chonan T; Tanaka H; Yamamoto D; Yashiro M; Oi T; Wakasugi D; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3965-8. PubMed ID: 20537533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1.
    Middleton DS; Maw GN; Challenger C; Jessiman A; Johnson PS; Million WA; Nichols CL; Price JA; Trevethick M
    Bioorg Med Chem Lett; 2006 Feb; 16(4):905-10. PubMed ID: 16290934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
    Qian W; Chen JJ; Human J; Aya T; Zhu J; Biswas K; Peterkin T; Hungate RW; Arik L; Johnson E; Kumar G; Joseph S; Jona J; Guo HX; Wu Z
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1061-7. PubMed ID: 22197141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.